Ablating Lung Cancer, Knowing the Tumor Better
Overview
Overview
Authors
Authors
Affiliations
Affiliations
Soon will be listed here.
Citing Articles
Perceptions and feelings of a French sample regarding lung cancer screening.
Darnaud N, Mory J, Romy P, Berger J, Eve K, Lantheaume S BMC Public Health. 2023; 23(1):2333.
PMID: 38001431 PMC: 10675874. DOI: 10.1186/s12889-023-17110-8.
Drug Repurposing in Non-Small Cell Lung Carcinoma: Old Solutions for New Problems.
Doumat G, Daher D, Zerdan M, Nasra N, Bahmad H, Recine M Curr Oncol. 2023; 30(1):704-719.
PMID: 36661704 PMC: 9858415. DOI: 10.3390/curroncol30010055.
References
1.
Debieuvre D, Molinier O, Falchero L, Locher C, Templement-Grangerat D, Meyer N
. Lung cancer trends and tumor characteristic changes over 20 years (2000-2020): Results of three French consecutive nationwide prospective cohorts' studies. Lancet Reg Health Eur. 2022; 22:100492.
PMC: 9445429.
DOI: 10.1016/j.lanepe.2022.100492.
View
2.
Cavic M, Kovacevic T, Zaric B, Stojiljkovic D, Korda N, Rancic M
. Lung Cancer in Serbia. J Thorac Oncol. 2022; 17(7):867-872.
DOI: 10.1016/j.jtho.2022.04.010.
View
3.
Rosell R, Karachaliou N
. Large-scale screening for somatic mutations in lung cancer. Lancet. 2016; 387(10026):1354-1356.
DOI: 10.1016/S0140-6736(15)01125-3.
View
4.
Jaiyesimi I, Temin S, Singh N
. Therapy for Stage IV Non-Small-Cell Lung Cancer With and Without Driver Alterations: ASCO Living Guidelines Q and A. JCO Oncol Pract. 2022; 18(10):699-702.
DOI: 10.1200/OP.22.00365.
View
5.
Field J, Vulkan D, Davies M, Baldwin D, Brain K, Devaraj A
. Lung cancer mortality reduction by LDCT screening: UKLS randomised trial results and international meta-analysis. Lancet Reg Health Eur. 2021; 10:100179.
PMC: 8589726.
DOI: 10.1016/j.lanepe.2021.100179.
View